Sodium oxybate (USAN) (brand names Xyrem, Alcover, Anetamin, Gamanest, Gioron, Somsanit), contracted from sodium γ-hydroxybutyrate, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of excessive daytime sleepiness (EDS) associated with narcolepsy, and by the FDA, Health Canada and in some areas of the United Kingdom National Health Service for the treatment of cataplexy associated with narcolepsy. Sodium oxybate is the sodium salt of γ-hydroxybutyric acid (GHB). Xyrem is manufactured by Jazz Pharmaceuticals in the US and Valeant Pharmaceuticals in Canada. Under the name Alcover, it is used in Italy for treatment of alcohol withdrawal and dependence.

CAS：502-85-2
中文别名：羟丁酸钠;
英文别名：4-Hydroxybutyrate sodium;gammaoh;GHB SODIUM SALT;sodium 4-hydroxybutanoate;4-hydroxybutyric acid sodium salt;SODIUM 4-HYDROXYBUTYRATE;somsanit;SODIUM OXYBATE;
分子式：C4H8NaO3+
分子量：127.094
精确质量：127.037
Psa：57.53
Logp：-0.1565

UNII：7G33012534

沸点：295.6ºC at 760mmHg
熔点：145-146ºC
闪点：146.8ºC
储存条件：Controlled Substance, -20ºC Freezer

安全说明：S24/25
海关编码：2918199090